ASCO Develops Recommendations for Invasive Cervical Cancer Care

This article originally appeared here.
Share this content:
ASCO Develops Recommendations for Invasive Cervical Cancer Care
ASCO Develops Recommendations for Invasive Cervical Cancer Care

TUESDAY, May 31, 2016 (HealthDay News) -- The American Society for Clinical Oncology (ASCO) has developed guidelines for the management and palliative care of women with invasive cervical cancer. The clinical practice guideline was published online May 25 in the Journal of Global Oncology.

Linus T. Chuang, M.D., from the Icahn School of Medicine at Mount Sinai in New York City, and colleagues developed recommendations on the management and palliative care of invasive cervical cancer. Systematic review of the literature failed to yield sufficiently strong quality evidence to support recommendations, so a formal consensus-based process was employed. Five sets of guidelines were reviewed as well as eight systematic reviews and cost-effectiveness analyses.

The authors note that clinicians should aim to provide access to the most effective evidence-based antitumor and palliative care interventions. If these cannot be accessed, patients may need to be treated with lower-tier modalities, depending on the capacity and resources for care. Cone biopsy or extrafascial hysterectomy may be performed for women with early-stage cervical cancer in basic settings. In non-basic settings, additional options may include fertility-sparing procedures or modified radical or radical hysterectomy. For women with stage IB to IVA disease, combinations of surgery, chemotherapy, and radiation therapy should be used, depending on available resources. An important aspect of palliative care is pain control.

"Health care providers and health care system decision makers should be guided by the recommendations for the highest stratum of resources available," the authors write.

Several authors disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions


Sign up for myCME e-newsletters


More in Home

Artificial Intelligence Promising for CA, Retinopathy Diagnoses

Artificial Intelligence Promising for CA, Retinopathy Diagnoses

Two studies evaluate use; one for breast cancer, the other for diabetic retinopathy

USPSTF Recommends Against Hormone Tx Post Menopause

USPSTF Recommends Against Hormone Tx Post Menopause

Benefits do not outweigh harms of using hormone therapy for prevention of chronic conditions

Omalizumab Ups Efficacy of Multifood Oral Immunotherapy

Omalizumab Ups Efficacy of Multifood Oral Immunotherapy

Findings in multifood allergic pediatric patients

is free, fast, and customized just for you!

Already a member?

Sign In Now »